Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 21 | 2022 | 423 | 1.530 |
Why?
|
| Infant, Premature | 4 | 2026 | 134 | 1.390 |
Why?
|
| Placenta | 5 | 2025 | 117 | 1.040 |
Why?
|
| Autonomic Nervous System | 2 | 2026 | 39 | 1.010 |
Why?
|
| Heart Rate | 4 | 2026 | 266 | 0.960 |
Why?
|
| Brain | 5 | 2026 | 1472 | 0.960 |
Why?
|
| Quantitative Trait Loci | 4 | 2022 | 88 | 0.960 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2022 | 863 | 0.950 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2026 | 587 | 0.860 |
Why?
|
| Heart Defects, Congenital | 4 | 2025 | 72 | 0.710 |
Why?
|
| Obesity | 13 | 2021 | 1151 | 0.630 |
Why?
|
| Models, Statistical | 1 | 2021 | 195 | 0.620 |
Why?
|
| Infant, Newborn | 10 | 2026 | 972 | 0.600 |
Why?
|
| Genetic Loci | 7 | 2018 | 104 | 0.600 |
Why?
|
| Heart Diseases | 2 | 2018 | 112 | 0.590 |
Why?
|
| Body Mass Index | 13 | 2018 | 925 | 0.580 |
Why?
|
| Apolipoproteins E | 1 | 2018 | 138 | 0.520 |
Why?
|
| Humans | 56 | 2026 | 43102 | 0.490 |
Why?
|
| Female | 40 | 2026 | 24698 | 0.480 |
Why?
|
| Blood Pressure | 2 | 2023 | 666 | 0.470 |
Why?
|
| Blood Glucose | 6 | 2019 | 389 | 0.470 |
Why?
|
| Genetic Predisposition to Disease | 13 | 2018 | 734 | 0.470 |
Why?
|
| Cognition | 2 | 2018 | 473 | 0.440 |
Why?
|
| Hippocampus | 1 | 2018 | 594 | 0.430 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 1001 | 0.430 |
Why?
|
| Male | 35 | 2026 | 23409 | 0.420 |
Why?
|
| Energy Intake | 5 | 2025 | 164 | 0.400 |
Why?
|
| Gestational Age | 4 | 2026 | 200 | 0.390 |
Why?
|
| Genotype | 9 | 2018 | 800 | 0.350 |
Why?
|
| Insulin | 4 | 2015 | 258 | 0.340 |
Why?
|
| Prospective Studies | 9 | 2026 | 1600 | 0.330 |
Why?
|
| Longitudinal Studies | 4 | 2025 | 1063 | 0.320 |
Why?
|
| Survival Analysis | 3 | 2021 | 368 | 0.310 |
Why?
|
| DNA Methylation | 3 | 2025 | 403 | 0.310 |
Why?
|
| Dietary Proteins | 3 | 2014 | 35 | 0.300 |
Why?
|
| Phenotype | 7 | 2022 | 780 | 0.300 |
Why?
|
| Exercise | 4 | 2022 | 692 | 0.300 |
Why?
|
| Organ Size | 2 | 2026 | 170 | 0.290 |
Why?
|
| Body Composition | 2 | 2019 | 159 | 0.290 |
Why?
|
| Pregnancy, High-Risk | 2 | 2025 | 8 | 0.280 |
Why?
|
| Pregnancy | 7 | 2026 | 1772 | 0.270 |
Why?
|
| Aged | 17 | 2022 | 8214 | 0.260 |
Why?
|
| Cardiovascular Diseases | 4 | 2023 | 749 | 0.250 |
Why?
|
| Aging | 2 | 2025 | 783 | 0.250 |
Why?
|
| Pregnancy in Diabetics | 1 | 2026 | 8 | 0.240 |
Why?
|
| Dietary Fats | 4 | 2014 | 117 | 0.240 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 291 | 0.230 |
Why?
|
| Parenteral Nutrition | 1 | 2025 | 15 | 0.230 |
Why?
|
| Diabetes, Gestational | 1 | 2026 | 56 | 0.230 |
Why?
|
| Aspartic Acid | 1 | 2025 | 51 | 0.230 |
Why?
|
| Soybean Oil | 1 | 2024 | 2 | 0.230 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2024 | 3 | 0.230 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2025 | 54 | 0.230 |
Why?
|
| Cerebellum | 1 | 2025 | 79 | 0.220 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2024 | 10 | 0.220 |
Why?
|
| Fetal Development | 1 | 2025 | 34 | 0.220 |
Why?
|
| Fish Oils | 1 | 2024 | 13 | 0.220 |
Why?
|
| Dietary Carbohydrates | 3 | 2014 | 34 | 0.220 |
Why?
|
| Heart Failure | 3 | 2018 | 302 | 0.220 |
Why?
|
| Birth Weight | 1 | 2025 | 95 | 0.220 |
Why?
|
| Adult | 17 | 2026 | 13872 | 0.210 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 140 | 0.210 |
Why?
|
| Middle Aged | 20 | 2022 | 12222 | 0.210 |
Why?
|
| Case-Control Studies | 6 | 2025 | 1285 | 0.200 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2025 | 301 | 0.190 |
Why?
|
| Transportation of Patients | 1 | 2022 | 14 | 0.190 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2019 | 81 | 0.180 |
Why?
|
| Triglycerides | 3 | 2019 | 147 | 0.180 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 236 | 0.180 |
Why?
|
| Risk Factors | 8 | 2019 | 3994 | 0.180 |
Why?
|
| Body Height | 2 | 2013 | 53 | 0.180 |
Why?
|
| Insulin Resistance | 2 | 2015 | 201 | 0.180 |
Why?
|
| Receptors, Cell Surface | 1 | 2022 | 146 | 0.170 |
Why?
|
| Patient Participation | 1 | 2022 | 94 | 0.170 |
Why?
|
| Gastric Bypass | 1 | 2021 | 22 | 0.170 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 23 | 0.170 |
Why?
|
| Proportional Hazards Models | 3 | 2018 | 518 | 0.170 |
Why?
|
| Bayes Theorem | 1 | 2021 | 126 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2022 | 259 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 2853 | 0.160 |
Why?
|
| Overweight | 2 | 2019 | 249 | 0.160 |
Why?
|
| Weight Loss | 1 | 2021 | 137 | 0.160 |
Why?
|
| Fibroblast Growth Factors | 3 | 2018 | 36 | 0.160 |
Why?
|
| Intensive Care Units | 2 | 2017 | 72 | 0.160 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 67 | 0.150 |
Why?
|
| Stress, Psychological | 1 | 2025 | 661 | 0.150 |
Why?
|
| Epistasis, Genetic | 2 | 2017 | 19 | 0.150 |
Why?
|
| Anorexia Nervosa | 1 | 2018 | 6 | 0.150 |
Why?
|
| Adiposity | 2 | 2017 | 157 | 0.150 |
Why?
|
| Cohort Studies | 7 | 2018 | 1759 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2021 | 408 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2018 | 44 | 0.140 |
Why?
|
| Depression | 1 | 2025 | 863 | 0.140 |
Why?
|
| Antihypertensive Agents | 1 | 2021 | 287 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 75 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 14 | 0.140 |
Why?
|
| Anxiety | 1 | 2025 | 874 | 0.140 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 19 | 0.140 |
Why?
|
| Seafood | 1 | 2017 | 26 | 0.140 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 284 | 0.130 |
Why?
|
| Critical Illness | 1 | 2017 | 47 | 0.130 |
Why?
|
| Alleles | 5 | 2016 | 352 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 89 | 0.120 |
Why?
|
| Receptors, Cytokine | 1 | 2016 | 11 | 0.120 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 67 | 0.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 167 | 0.120 |
Why?
|
| Expiratory Reserve Volume | 1 | 2015 | 2 | 0.120 |
Why?
|
| Functional Residual Capacity | 1 | 2015 | 2 | 0.120 |
Why?
|
| Patient Selection | 1 | 2017 | 205 | 0.120 |
Why?
|
| Meat Products | 1 | 2015 | 5 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 17 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 28 | 0.120 |
Why?
|
| Meat | 1 | 2015 | 46 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2019 | 392 | 0.110 |
Why?
|
| Sepsis | 1 | 2016 | 90 | 0.110 |
Why?
|
| Coffea | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 61 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 122 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 73 | 0.110 |
Why?
|
| Fasting | 2 | 2012 | 56 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2025 | 760 | 0.100 |
Why?
|
| Chromosome Mapping | 2 | 2012 | 199 | 0.100 |
Why?
|
| Hypertension | 1 | 2021 | 835 | 0.100 |
Why?
|
| Logistic Models | 1 | 2016 | 1009 | 0.100 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 5 | 0.100 |
Why?
|
| Hematopoiesis | 1 | 2013 | 27 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 26 | 0.100 |
Why?
|
| Dietary Fiber | 1 | 2013 | 51 | 0.100 |
Why?
|
| Anthropometry | 1 | 2013 | 97 | 0.100 |
Why?
|
| Trace Elements | 1 | 2013 | 35 | 0.100 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2013 | 47 | 0.100 |
Why?
|
| Smoking | 2 | 2017 | 1024 | 0.090 |
Why?
|
| Magnesium | 1 | 2013 | 94 | 0.090 |
Why?
|
| Lung | 1 | 2015 | 492 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 502 | 0.090 |
Why?
|
| Weight Gain | 1 | 2013 | 139 | 0.090 |
Why?
|
| Blood Proteins | 1 | 2012 | 77 | 0.090 |
Why?
|
| Waist-Hip Ratio | 3 | 2017 | 34 | 0.090 |
Why?
|
| Models, Genetic | 1 | 2012 | 183 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 310 | 0.090 |
Why?
|
| Proteins | 1 | 2014 | 382 | 0.090 |
Why?
|
| Homeostasis | 1 | 2012 | 192 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2011 | 40 | 0.090 |
Why?
|
| Coronary Disease | 1 | 2012 | 123 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 35 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 79 | 0.080 |
Why?
|
| Lipids | 1 | 2012 | 256 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2014 | 469 | 0.080 |
Why?
|
| Zinc | 1 | 2011 | 131 | 0.080 |
Why?
|
| Stem Cells | 1 | 2011 | 152 | 0.080 |
Why?
|
| Educational Status | 2 | 2022 | 339 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 429 | 0.070 |
Why?
|
| United States | 5 | 2018 | 5205 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 3156 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2011 | 329 | 0.070 |
Why?
|
| Waist Circumference | 2 | 2017 | 90 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2012 | 518 | 0.060 |
Why?
|
| Diet | 1 | 2012 | 826 | 0.060 |
Why?
|
| Genomics | 2 | 2018 | 293 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2026 | 27 | 0.060 |
Why?
|
| Comorbidity | 2 | 2019 | 737 | 0.060 |
Why?
|
| Sex Factors | 2 | 2019 | 1028 | 0.060 |
Why?
|
| Reference Values | 1 | 2025 | 211 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2019 | 430 | 0.060 |
Why?
|
| Transposition of Great Vessels | 1 | 2024 | 3 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2017 | 210 | 0.060 |
Why?
|
| Paraffin Embedding | 1 | 2024 | 15 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2025 | 53 | 0.050 |
Why?
|
| Glutamic Acid | 1 | 2025 | 131 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2025 | 67 | 0.050 |
Why?
|
| Child Development | 1 | 2024 | 99 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2024 | 185 | 0.050 |
Why?
|
| Age Factors | 2 | 2019 | 1154 | 0.050 |
Why?
|
| Prognosis | 2 | 2018 | 861 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2012 | 86 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 638 | 0.050 |
Why?
|
| Amyloid | 1 | 2023 | 65 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 93 | 0.050 |
Why?
|
| Linear Models | 2 | 2013 | 317 | 0.040 |
Why?
|
| Memory | 1 | 2022 | 174 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2019 | 34 | 0.040 |
Why?
|
| Prevalence | 2 | 2016 | 1612 | 0.040 |
Why?
|
| Physical Fitness | 1 | 2019 | 90 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1070 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 27 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2018 | 103 | 0.040 |
Why?
|
| Europe | 1 | 2017 | 115 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 182 | 0.030 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 26 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 440 | 0.030 |
Why?
|
| District of Columbia | 1 | 2017 | 80 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2018 | 263 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2022 | 706 | 0.030 |
Why?
|
| Heterozygote | 1 | 2016 | 110 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 2016 | 7 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1604 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 355 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2016 | 87 | 0.030 |
Why?
|
| Residual Volume | 1 | 2015 | 2 | 0.030 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2015 | 5 | 0.030 |
Why?
|
| Total Lung Capacity | 1 | 2015 | 5 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 229 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 61 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 437 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 189 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 118 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 20 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 28 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2018 | 561 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2014 | 67 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2014 | 206 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 2544 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 5080 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 35 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 12 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2013 | 14 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2013 | 19 | 0.020 |
Why?
|
| Massachusetts | 1 | 2013 | 35 | 0.020 |
Why?
|
| Adolescent | 2 | 2015 | 6081 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2013 | 33 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1078 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 213 | 0.020 |
Why?
|
| Ribosomes | 1 | 2012 | 35 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 40 | 0.020 |
Why?
|
| Netherlands | 1 | 2012 | 14 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 99 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 25 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2012 | 99 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2013 | 224 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 150 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 59 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 95 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 159 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 132 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 148 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2013 | 169 | 0.020 |
Why?
|
| Life Style | 1 | 2013 | 334 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 223 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 321 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 49 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 1067 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 358 | 0.020 |
Why?
|
| Glucose | 1 | 2011 | 244 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 375 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 561 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 863 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 760 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 6644 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 16992 | 0.010 |
Why?
|